Abbott Shifts Meridia Marketing Focus From Consumer To Physicians

Abbott plans to move away from direct-to-consumer advertising for the anti-obesity agent Meridia (sibutramine) in favor of marketing aimed more directly at healthcare providers.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet